Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Immunology
Импакт фактор: 1.404 5-летний Импакт фактор: 3.347 SJR: 0.706 SNIP: 0.55 CiteScore™: 2.19

ISSN Печать: 1040-8401
ISSN Онлайн: 2162-6472

Выпуски:
Том 40, 2020 Том 39, 2019 Том 38, 2018 Том 37, 2017 Том 36, 2016 Том 35, 2015 Том 34, 2014 Том 33, 2013 Том 32, 2012 Том 31, 2011 Том 30, 2010 Том 29, 2009 Том 28, 2008 Том 27, 2007 Том 26, 2006 Том 25, 2005 Том 24, 2004 Том 23, 2003 Том 22, 2002 Том 21, 2001 Том 20, 2000 Том 19, 1999 Том 18, 1998 Том 17, 1997 Том 16, 1996 Том 15, 1995 Том 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v20.i1.10
16 pages

Immunomodulation of Experimental Autoimmune Diseases via Oral Tolerance

Ilan Krause
Research Unit of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer 52621, Sackler Faculty of Medicine, Tel-Aviv University, Israel
Miri Blank
Research Unit of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer 52621, Sackler Faculty of Medicine, Tel-Aviv University, Israel
Yehuda Shoenfeld
Research Unit of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer 52621, Sackler Faculty of Medicine, Tel-Aviv University, Israel

Краткое описание

The concept of oral tolerance refers to a form of peripheral tolerance in which mature lymphocytes in the peripheral lymphoid tissues are rendered nonfunctional or hyporesponsive by prior oral administration of an antigen. The primary mechanisms mediating oral tolerance include deletion, anergy of antigen-specific T cells and active cellular suppression, the primary determining factor being the dose of fed antigen. Low doses favor active suppression, whereas high doses favor deletion and anergy. Active cellular suppression is mediated by the induction of regulatory T cells in the gut-associated lymphoid tissue, which migrate to the systemic immune system. One of the primary mechanisms of active cellular suppression is via secretion of suppressive cytokines such as TGF-β, IL-4, and IL-10 following antigen-specific triggering. TGF-β is produced both by CD4+ and CD8+ GALT-derived T cells and is an important mediator of the active suppression component of oral tolerance. CD4+ cells that primarily produce TGF-β appear to be a unique T-cell subset and termed Th3 cells. Oral tolerance was successfully studied in a variety of experimental models for autoimmune diseases, among them experimental autoimmune encephalomyelitis, experimental arthritis, experimental anti-phospholipid syndrome, experimental autoimmune uveoretinitis, experimental insulin dependent diabetes mellitus (IDDM), and experimental autoimmune myasthenia gravis. The results obtained in experimental animal models have led to the conduction of several clinical trials of oral tolerance in patients with multiple sclerosis, rheumatoid arthritis, uveitis, and IDDM. Conflicting results were obtained, and although some improvement has been noted in some of the patients, broad ranging clinical improvement has not yet been observed. A more accurate choice of antigens, as well as more precise dosing and timing of antigen-administration might lead to better results in the future.


Articles with similar content:

Immunological Mechanisms Involved In Experimental Peptide Immunotherapy of T-Cell-Mediated Diseases
Critical Reviews™ in Immunology, Vol.20, 2000, issue 6
Marca H. M. Wauben
Cellular Components and Mechanisms of Oral Tolerance Induction
Critical Reviews™ in Immunology, Vol.38, 2018, issue 3
Rafael M. Rezende, Howard L. Weiner
Structure of IL-10 and Its Role in Autoimmune Exocrinopathy
Critical Reviews™ in Immunology, Vol.20, 2000, issue 2
Ichiro Saito
Mechanisms of Induction of Tolerance to Organ Allografts
Critical Reviews™ in Immunology, Vol.20, 2000, issue 4
Bruce Hall
T-Cell Control of Immunity to the Asexual Blood Stages of the Malaria Parasite
Critical Reviews™ in Immunology, Vol.14, 1994, issue 2
Klavs Berzins, Marita Troye-Blomberg, Peter Perlmann